NCT07625761

Brief Summary

The Iowa Oral Performance Instrument (IOPI) is currently the reference tool for assessing tongue muscle function, measuring the pressure exerted by the tongue on an air-filled bulb. However, several limitations reduce its precision and clinical relevance. To overcome these, the TOngue Manometer (TOM) has been developed. This crossover study compares the two devices in healthy adults, hypothesizing that the TOM's interface will enable participants to produce higher maximal tongue pressure and endurance values, closer to their ground truth.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
17mo left

Started May 2026

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
May 2026Dec 2027

First Submitted

Initial submission to the registry

May 5, 2026

Completed
25 days until next milestone

Study Start

First participant enrolled

May 30, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 4, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

June 4, 2026

Status Verified

May 1, 2026

Enrollment Period

1.2 years

First QC Date

May 5, 2026

Last Update Submit

May 28, 2026

Conditions

Keywords

AdultsHealthytonguemuscles

Outcome Measures

Primary Outcomes (2)

  • Tongue Pmax in elevation (pElev)

    Tongue maximal pressure (kPa) in elevation, either with the TOM or the IOPI, depending on the visit and the randomization order

    Throughout the entire study, approximately during 14 months

  • Tongue endurance in elevation (eElev)

    Endurance time (sec.), i.e., time during which the tongue can sustain 50% of its Pmax in elevation, measured either with the TOM or the IOPI, depending on the visit and the randomization order

    Throughout the entire study, approximately during 14 months

Secondary Outcomes (4)

  • Body mass index (kg/m^2)

    Throughout the entire study, approximately during 14 months

  • Mouth, tongue, and face assessment test (through MBLF test)

    Throughout the entire study, approximately during 14 months

  • Mouth breathing questionnaire

    Throughout the entire study, approximately during 14 months

  • Tongue thickness (POCUS)

    Throughout the entire study, approximately during 14 months

Study Arms (2)

TOM session

EXPERIMENTAL
Device: TOngue Manometer (TOM) device

IOPI session

ACTIVE COMPARATOR
Device: IOPI

Interventions

New, lab-made device

TOM session
IOPIDEVICE

The device currently identified as gold standard for tongue muscles assessment

IOPI session

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being a healthy adult aged 18 to 65 years old
  • Being able to understand and speak French

You may not qualify if:

  • Being diagnosed with a cardiorespiratory or neuromuscular disease
  • Being diagnosed with obstructive sleep apnea-hypopnea syndrome
  • Any reason preventing the participant from completing the measurement protocol (e.g., oral pain, severe cognitive impairment, lack of cooperation, illiteracy)
  • Being involved in an oropharyngeal rehabilitation program
  • Having dysphagia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut de Recherche Expérimentale et Clinique (IREC) - UCLouvain; Lung, Nose, and Skin (LUNS) lab

Brussels, 1200, Belgium

Location

Study Officials

  • William Poncin, PhD

    Université Catholique de Louvain

    STUDY CHAIR

Central Study Contacts

Pierre Cnockaert, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2026

First Posted

June 4, 2026

Study Start

May 30, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

June 4, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations